ADDED ADVANTAGE OF INJECTING SUBTARSAL STEROID INJECTION AFTER INCISION AND CURETTAGE OF MULTIPLE CHALAZION
AbstractBackground: Being one of the most common eye lid inflammatory lesion, there is an abundance of ways its treatment can be approached; however, the dearth of consensus on its management guidelines still remains a point of interest in peer reviewed literature. Purpose: To evaluate the additional advantage of injecting subtarsal steroid injection simultaneously with incision and curettage of multiple eye lid chalazion. Method: This intervention study was carried out in the Ophthalmology unit of Khalid Eye Clinic, Karachi from February to July 2019 and included fifty patients of both male and female with age ranging between 15–45 years. The patients were distributed into two groups with twenty-five patients in each group. Group A included patients undergoing incision and curettage only for eye lid multiple chalazion, whereas, Group B included patients undergoing incision and curettage with simultaneous subtarsal steroid injection. Post operatively patients were advised to do hot compresses for at least five days and observe the resolution of swelling and recurrence of chalazion for up to six months. Result: The average time for resolution of the swelling in group A patients was 4.4±1.45 days, but eleven out of the twenty-five patients developed chalazion on the same eye lid again within the follow up period. Although group B patients took 6.0±2.7 days for the resolution of swelling but none of them developed recurrent chalazion within the follow up period. Conclusion: Patients undergoing incision and curettage with simultaneous steroid injection proved to have an additional benefit in terms of reduction in recurrence of chalazion.
Arbabi EM, Kelly RJ, Carrim ZI. Chalazion. BMJ 2010;341:c4044.
Pizzarello LD, Jakobeic FA, Hofeldt AJ, Podolsky MM, Slivers DN. Intralesional corticosteroid therapy of chalazia. Am J Ophthalmol 1978;85(6):818–21.
Cottrell DG, Bosanquet RC, Fawcett IM. Chalazions: the frequency of spontaneous resolution. Br Med J (Clin Res Ed) 1983;287(6405):1595.
Bohigian GM. Chalazion: a clinical evaluation. Ann Ophthalmol 1979;11(9):1397–8.
Garrett GW, Gillespie ME, Mannix BC. Adrenocorticosteroid injection vs. conservative therapy in the treatment of chalazia. Ann Ophthalmol 1988;20(5):196–8.
Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology 1980;87:218–21.
Ben Simon GJ, Huang L, Nakra T, Schwarcz RM, McCann JD, Goldberg RA. Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really eff ective? Ophthalmology; 2005;112(5):913–7.
Goawalla A, Lee V. A prospective randomized treatment study comparing three treatment options for chalazia: triamcinolone acetonide injections, incision and curettage and treatment with hot compresses. ClinExp Ophthalmol 2007;35(8):706–12.
Palva J, Pohjanpelto PE. Intralesional corticosteroid injection for the treatment of chalazia. Acta Ophthalmol (Copenh) 1983;61(5):933–7.
Ozdal PC, Codère F, Callejo S, Caissie AL, Burnier MN. Accuracy of the clinical diagnosis of chalazion. Eye 2004;18(2):135–8.
Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004;111(12):2151–7.
Jackson TL, Beun L. A prospective study of cost, patient satisfaction, and outcome of treatment of chalazion by medical and nursing staff. Br J Ophthalmol 2000;84(7):782–5.
Ahmad S, Baig MA, Khan MA, Khan IU, Janjua TA. Intralesional corticosteroid injection vs surgical treatment of chalazia in pigmented patients. J Coll Physicians Surg Pak 2006;16(1):42–4.
Castern J, Stenberg T. Corticosteroid injection of chalazia. Acta Ophthalmol (Copenh) 1983;61(5):938–42.
Leinfelder PJ. Depo-medrol in treatment of acute chalazion. Am J Ophthalmol 1964;58:1078.
Biuk D, Matić S, Barać J, Vuković MJ, Biuk E, Matić M. Chalazion management: surgical treatment versus triamcinolon application. Coll Antropol 2013;37(Suppl 1):247–50.
Costea CF, Petraru D, Dumitrescu G, Sava A. Sebaceous carcinoma of the eyelid: anatomoclinical data. Rom J Morphol Embryol 2013;54(3):665–8.
Thabit A. Ismat H. Three methods of treatment of Chalazia in children. Saudi Med J 2001;22(11):968–72.
Norris JH. Intralesional triamcinolone acetonide injection versus incision and curettage for primary chalazia: a prospective, randomized study. Am J Ophthalmol 2012;153(5):1005–6.
Wong MY, Yau GS, Lee JW, Yuen CY. Management of chalazion in pediatric patients by intralesional triamcinolone acetonide injection. Hong Kong J Ophthalmol 2014;18(1):26–9.
Chung CF, Lai JS, Li PS. Subcutaneous extralesional triamcinolone acetonide injection versus conservative management in the treatment of chalazion. Hong Kong Med J 2006;12(4):278–81.
Cohen BZ, Tripathi RC. Eyelid depigmentation after intralesional injection of a fluorinated corticosteroid for chalazion. Am J Ophthalmol 1979;88(2):269–70.
Hoşal BM, Zilelioğlu G. Ocular complication of intralesional corticosteroid injection of a chalazion. Eur J Ophthalmol 2003;13(9-10):798–9.
Thomas EL, Laborde RP. Retinal and choroidal vascular occlusion following intralesional corticosteroid injection of a chalazion. Ophthalmology 1986;93(3):405–7.
Ho SY, Lai JS. Subcutaneous steroid injection as treatment for chalazion: prospective case series. Hong Kong Med J 2002;8(1):18–20.